Top 10 Pharma Companies in Japan in 2021 by R&D Expenditure

Takeda Pharmaceutical Co Ltd, Daiichi Sankyo Co Ltd, Astellas Pharma Inc, Otsuka Holdings Co Ltd, and Eisai Co Ltd are the top 5 pharma companies in Japan in 2021 by R&D expenditure. Cumulatively, the top 10 pharma companies in Japan reported a total R&D expenditure of $16,521 million, where the highest R&D expenditure was reported by Takeda Pharmaceutical Co Ltd ($4,684 million), followed by Daiichi Sankyo Co Ltd ($2,317 million) and Astellas Pharma Inc ($2,190 million), while the lowest R&D expenditure was reported by Kyowa Kirin Co Ltd ($513 million). Japan-based Takeda Pharmaceutical Co Ltd is one of the leading pharma companies in 2021 by R&D expenditure. It is a research-based pharmaceutical company that focuses on the discovery, development, manufacturing, marketing, commercialization, import, and export of pharmaceutical drugs. The company offers products in the areas of rare diseases, gastrointestinal, oncology, neuroscience, vaccines, and plasma-derived therapies. The company reported revenue of $31,773 million for the fiscal year ended March 2022 (FY2022), an increase of 5.33% over FY2021. It has a presence in approximately 80 countries and employs 47,347 people. Daiichi Sankyo Co Ltd is one leading pharma companies in Japan in 2021 by R&D expenditure. It is a holding company, which develops, manufactures, and markets drugs to address unmet medical needs in various diseases and disorders. The company operates through three segments: Prescription drugs, Healthcare (OTC) products, and Others. The company reported revenue of $9,302 million for the fiscal year ended March 2022 (FY2022), an increase of 2.45% over FY2021. The company operates through three segments: Prescription drugs, Healthcare (OTC) products, and Others. It has operations in North America, South and Central America, Europe, and Asia, and employed 16,458 people.